ArticleBMC oral health2025
Edentulism as an independent risk factor for sarcopenia: evidence from cross-sectional and longitudinal analyses based on the CHARLS cohort.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Edentulism and incident hip fracture among middle-aged and older adults in China: evidence from the CHARLS.BMC public health · 2026Article
- Bidirectional association between edentulism and sarcopenia in Chinese middle-aged and older adults: a nationally representative longitudinal cohort study.Clinical oral investigations · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundEdentulism and sarcopenia are two highly prevalent, age-related conditions that share common nutritional, inflammatory, and functional pathways. Whether tooth loss independently contributes to the development of sarcopenia-and in which population strata this effect is strongest-remains uncertain, especially in Asian cohorts.
methodsWe analysed 17,099 participants (baseline 2011) from the China Health and Retirement Longitudinal Study (CHARLS). Sarcopenia was defined by Asian Working Group for Sarcopenia 2019 criteria. Multivariable logistic models were fitted for cross-sectional analysis (wave 1). For longitudinal analysis (waves 1-3, seven-year follow-up), Cox proportional hazards models were fitted as the primary analysis, with logistic regression models applied as supplementary sensitivity analyses. Models were fitted sequentially: Model 1 (crude), Model 2 (plus demographic covariates), Model 3 (plus metabolic/inflammatory factors). Results were reported as odds ratios (OR) and hazard ratios (HR) with 95% confidence intervals (CI). Propensity-score matching (PSM) was applied to minimise selection bias. Subgroup analyses covered sex, residence, marital status, education, smoking, drinking, and region. Sensitivity analyses tested robustness.
resultsEdentulism prevalence was 8.8%; sarcopenia prevalence, 15.0%. Cross-sectionally, edentulism increased sarcopenia risk in Model 1 (OR = 3.89, 95%CI: 3.46-4.37, P < 0.001) and remained significant after full adjustment (OR = 1.31, 95%CI: 1.04-1.66, P = 0.023). In the PSM set, the effect strengthened (Model 3: OR = 1.57, 95%CI: 1.15-2.14, P = 0.004). Longitudinally, Cox analyses showed edentulism predicted incident sarcopenia in PSM data (Model 3: HR = 1.21, 95%CI: 1.05-1.40, P = 0.008). Supplementary logistic regression analyses in the PSM set yielded consistent findings (Model 3: OR = 1.047, 95%CI: 1.009-1.086, P = 0.014). Subgroup analyses showed consistently higher risks in males, rural residents, low-education groups, non-smokers, non-drinkers, and western regions.
conclusionsEdentulism is a robust, independent marker of elevated sarcopenia risk in Chinese adults, with particularly strong effects in socio-economically vulnerable subgroups. Routine oral-health screening should be integrated into geriatric assessments to identify patients at high risk for sarcopenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.